2,403
Views
27
CrossRef citations to date
0
Altmetric
Review

Exploring the role of non-coding RNAs in autophagy

, , , , ORCID Icon & ORCID Icon
Pages 949-970 | Received 25 Sep 2020, Accepted 27 Jan 2021, Published online: 18 Feb 2021

ABSTRACT

As a self-degradative mechanism, macroautophagy/autophagy has a role in the maintenance of energy homeostasis during critical periods in the development of cells. It also controls cellular damage through the eradication of damaged proteins and organelles. This process is accomplished by tens of ATG (autophagy-related) proteins. Recent studies have shown the involvement of non-coding RNAs in the regulation of autophagy. These transcripts mostly modulate the expression of ATG genes. Both long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have been shown to modulate the autophagy mechanism. Levels of several lncRNAs and miRNAs are altered in this process. In the present review, we discuss the role of lncRNAs and miRNAs in the regulation of autophagy in diverse contexts such as cancer, deep vein thrombosis, spinal cord injury, diabetes and its complications, acute myocardial infarction, osteoarthritis, pre-eclampsia and epilepsy.

Abbreviations: AMI: acute myocardial infarction; ATG: autophagy-related; lncRNA: long non-coding RNA; miRNA: microRNA.

Introduction

Autophagy is a degradative mechanism that regulates the energy resources at crucial times during development and in periods of nutrient deficiency [Citation1]. This process is also involved in the removal of protein aggregates, elimination of impaired organelles, as well as intracellular pathogens. Autophagy is regarded as a recycling mechanism to enhance energy proficiency through ATP production and governs cellular damage through the eradication of damaged proteins and organelles [Citation1]. Autophagy is accomplished through multiple steps. First, stress-related pathways regulate phagophore formation through modulation of the BECN1/Beclin 1-PIK3C3/VPS34-containing phosphatidylinositol 3-kinase complex at the endoplasmic reticulum. Subsequent multimerization of proteins coded by ATG (autophagy-related) genes and MAP1LC3/LC3 occurs at the phagophore membrane. Then, a number of targets are selected to be degraded and the autophagosome is fused with the lysosome to degrade the trapped molecules through proteolytic reactions [Citation1]. Several ATG proteins participate in autophagy. Notably, many of the corresponding genes are conserved between species [Citation2].

Macroautophagy, microautophagy, and chaperone-mediated autophagy are the principal types of autophagy. All three types lead to proteolytic destruction of cytosolic apparatuses in the cellular lysosomes [Citation3]. Yet, the route of delivery of cytoplasmic elements to the lysosomes differs between these types as in the macroautophagy autophagosome delivers these elements while in the micro-autophagy cytosolic apparatuses are directly delivered to the lysosome. In chaperone-mediated autophagy, targeted proteins are delivered in a complex with chaperone proteins that interact with the lysosomal membrane receptor. This interaction leads to protein unfolding and destruction [Citation3]. Autophagy is regulated by several mechanisms. Among the recently appreciated mechanisms is the involvement of non-coding RNAs (ncRNAs) [Citation4]. It has been revealed that 98% of the genome is transcribed. However, the majority of these transcripts do not encode proteins, thus being described as ncRNAs [Citation5]. Regulatory ncRNAs comprise a significant portion of ncRNAs, with long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) being the most important classes of this group of transcripts. These transcripts can regulate the expression of several genes at the epigenetic, transcriptional, and post-transcriptional levels [Citation5]. Nearly all miRNAs are considered as post-transcriptional suppressors of gene expression. However, lncRNAs can regulate expression of protein-coding genes at both positive and negative directions via different interactions with RNA, protein and chromatin structures [Citation6]. Several lncRNAs have been shown to be evolutionarily conserved [Citation7], albeit to a lesser extent compared with protein-coding genes [Citation8]. It is worth mentioning that the levels of conservation in the promoter areas of lncRNAs are similar to the promoters of several protein-coding genes [Citation6]. Numerous miRNAs have been identified in mammalian genomes, several of them being highly conserved even between remotely related species [Citation9]. While lncRNAs are generated by POLR2 (RNA polymerase II) and POLR3 (RNA polymerase III) [Citation10], miRNAs are transcribed from genomic DNA into primary miRNAs, then being processed into precursor miRNAs and mature miRNAs in a sequential process [Citation10]. Both lncRNAs and miRNAs have been shown to modulate the autophagy mechanism. In the present review, we discuss the role of lncRNAs and miRNAs in the regulation of autophagy in diverse contexts such as cancer, deep vein thrombosis, spinal cord injury, diabetes and its complications, acute myocardial infarction, osteoarthritis, pre-eclampsia and epilepsy. In order to find the relevant literature, we searched PubMed and Google Scholar with the keywords “autophagy” AND “miRNA” or “lncRNA”. Then, we assessed the full texts of the articles to extract data regarding type of disorder, clinical samples, animal models and the molecular pathways being influenced by miRNAs/lncRNAs. Finally, we tabulated the extracted data in order to make the data more comprehensible. It is worth mentioning that the majority of the included studies have assessed the role of miRNA/lncRNAs through functional studies, thus providing enough evidence for contribution of these ncRNAs in the regulation of autophagy.

miRNAs and autophagy

These transcripts have sizes of approximately 22 nucleotides and principally regulate the expression of their target genes at the post-transcriptional level [Citation11]. Several experiments have shown the role of miRNAs in the regulation of autophagy. Dysregulation of miRNAs has been associated with a wide range of disorders, including cancers and nonmalignant disorders.

miRNA and autophagy in cancer

Expression of MIR100 is decreased in renal cell carcinoma cell lines and clinical samples compared with adjacent non-cancerous tissues, while the expression of its target gene, NOX4, is increased in malignant samples. Overexpression of this miRNA or knockdown of its target in the mentioned cell lines has enhanced autophagy while reducing the expression of MTOR (mechanistic target of rapamycin kinase) pathway-associated genes and cancer cell migration and invasion [Citation12]. MIR126 is downregulated in colorectal cancer cells and tissues compared with normal tissues. Forced upregulation of this miRNA compromised viability and growth of these cells and enhanced both autophagy and apoptosis through modulation of expression of the MTOR gene [Citation13]. MIR30A regulates autophagy in hepatocellular carcinoma [Citation14] and gastrointestinal stromal tumor [Citation15]. miRNAs with regulatory roles on the autophagy can also affect epithelial-mesenchymal transition (EMT), thus influencing the metastatic ability of cancer cells [Citation16]. depicts the underlying mechanism of the contribution of two miRNAs in the autophagy and EMT process in the context of gastric cancer.

Figure 1. H. pylori increases MIR543 levels in gastric cancer. This miRNA binds with the 3ʹ UTR of SIRT1 to inhibit its expression. Autophagy has a role in the inhibition of epithelial-mesenchymal transition (EMT) in some situations [Citation16]. Conversely, MIR532-3p levels are decreased in gastric cancer. This miRNA inhibits the expression of RAB3IP. Overexpression of RAB3IP is associated with a decrease in autophagy and enhancement of EMT [Citation79].

Figure 1. H. pylori increases MIR543 levels in gastric cancer. This miRNA binds with the 3ʹ UTR of SIRT1 to inhibit its expression. Autophagy has a role in the inhibition of epithelial-mesenchymal transition (EMT) in some situations [Citation16]. Conversely, MIR532-3p levels are decreased in gastric cancer. This miRNA inhibits the expression of RAB3IP. Overexpression of RAB3IP is associated with a decrease in autophagy and enhancement of EMT [Citation79].

miRNAs and autophagy in cardiac disorders

Overexpression of MIR26B-5p, MIR204-5p, and MIR497-3p reduces IGF1 (insulin like growth factor 1)-induced cardiomyocyte hypertrophy by inhibiting autophagy [Citation17]. Several miRNAs have been identified that regulate autophagy in the context of acute myocardial infarction (AMI). For instance, overexpression of MIR139-5p could prevent cell autophagy induced by hypoxia-reoxygenation injury [Citation18]. Moreover, MIR638 and MIR384 have functional roles in the reduction of cell autophagy by modulating the expression of ATG5 and activation of the phosphoinositide 3-kinase (PI3K)-AKT/protein kinase B pathway, respectively [Citation19,Citation20]. Conversely, the downregulation of MIR30A can prevent autophagy in myocardial cells [Citation21]. Additionally, MIR30A suppresses BECN1-associated autophagy in diabetic cataract [Citation22]. MIR9-5p has a role in increasing migration, invasion, and angiogenesis of endothelial progenitor cells by lessening TRPM7 transcription through induction of PI3K-AKT-related autophagy. Based on the role of endothelial progenitor cells in resolving thrombi, this miRNA has been suggested as a therapeutic target in deep vein thrombosis [Citation23].

miRNAs and autophagy in osteoarthritis

Several miRNAs have been implicated in the pathogenesis of osteoarthritis via different mechanisms. For instance, MIR27A has a role in the down-regulation of PI3K and subsequent increase in autophagy in IL1B/IL-1β-treated chondrocytes [Citation24]. Conversely, MIR128-1 can suppress chondrocyte autophagy by disturbing ATG12 [Citation25]. MIR4262 also has a role in the development of osteoarthritis by modulating cell autophagy [Citation26]. Expression of MIR375 has been increased in cartilage tissues obtained from osteoarthritis cases, while ATG2B expression has been diminished in these samples. MIR375-mediated suppression of ATG2B in the chondrocytes inhibits autophagy and enhances endoplasmic reticulum stress, thus exacerbating osteoarthritis clinical symptoms [Citation27].

miRNA and autophagy in inflammatory bowel diseases

Several miRNAs have been shown to affect autophagy, thus contributing to the pathogenesis of inflammatory bowel disease. For instance, MIR196A and MIR196B can reduce the expression of IRGM and inhibit autophagy by decreasing the accumulation of LC3-II [Citation28]. Besides, the expression of MIR665 has been increased in the intestinal mucosa of patients with inflammatory bowel disease. This miRNA can decrease the expression of XBP1 and ORMDL3 in the course of endoplasmic reticulum stress, enhancing autophagy sensitivity [Citation29]. Finally, the upregulation of MIR221-5p in colitis tissues has been associated with overexpression of SP, implying its role in inflammatory bowel disease autophagy [Citation30].

shows the list of miRNAs that are involved in the process of autophagy.

Table 1. List of autophagy-associated miRNAs

Based on the fundamental roles of autophagy in the development of cancer and its course, expression of autophagy-associated miRNAs can predict cancer patients’ survival. Higher expressions of MIR221, MIR135A1-5p, MIR150, and MIR449A have been associated with unfavorable outcome in patients with colorectal cancer, hepatocellular carcinoma, non-small cell lung carcinoma, and glioma, respectively [Citation31–34]. summarizes the results of studies that assessed the association between expression levels of autophagy-related miRNAs and the survival of cancer patients.

Table 2. Association between the survival of cancer patients and miRNAs that functionally affect autophagy (the expression of miRNAs could be associated with the prognosis independently of autophagy regulation)

LncRNAs and autophagy

LncRNAs are transcripts comprising more than 200 nucleotides, devoid of protein-coding capacity, which are expressed in several tissues and exert regulatory roles on the expression of target genes. Several lncRNAs have been identified that influence the process of autophagy. As autophagy is involved in the pathogenic process of several human disorders, these lncRNAs participate in diverse disorders ranging from cancer to age-related pathologies.

lncRNA and autophagy in cancer

HOTAIR can enhance autophagy through the regulation of ATG3 and ATG7 in hepatocellular carcinoma [Citation35]. Also, MALAT1 can activate autophagy in glioblastoma through the MIR101-3p-STMN1-ATG4D and MIR384-GOLM1 axes [Citation36,Citation37]. NEAT1 has a role in conferring resistance to 5-fluorouracil in colorectal cancer cells through modulation of MIR34A [Citation38]. HULC can modulate cisplatin resistance in gastric cancer through the regulation of FOXM1 expression and suppression of autophagy [Citation39]. This lncRNA enhances the malignant progression of hepatocellular carcinoma cells via reducing expression of MIR15A and increasing expression of SQSTM1/p62. Moreover, the overexpression of HULC enhances LC3 levels and subsequently induces LC3 via SIRT1. HULC also promotes the interaction between LC3 and ATG3. Also, HULC enhances the expression of BECN1. Taken together, HULC increases autophagy through SIRT1-mediated overexpression of LC3-II. HULC also suppresses PTEN expression via autophagy-SQSTM1 and ubiquitin–proteasome mechanisms [Citation40]. shows the mechanism of participation of HULC in the carcinogenesis.

Figure 2. The expression of HULC is increased in hepatocellular carcinoma. This lncRNA inhibits METTL3 binding with pri-MIR15A and decreases methylation of pri-MIR15A. Besides, HULC precludes binding of DGCR8 and DROSHA with this pri-miRNA, leading to a significant reduction in the levels of mature MIR15A. Downregulation of this miRNA results in the upregulation of SQSTM1, which contributes to the formation of autophagosome, suppression of PTEN, and induction of cancer [Citation40]. On the other hand, HULC enhances the binding of METTL3 with pri-MIR675 and increases MIR675 levels. This miRNA binds with 3ʹ UTR of HDAC5 mRNA and decreases its expression. Therefore, SIRT1 levels and the formation of autophagosomes are enhanced. This increases CCND1 synthesis and promotes the proliferation of cancer stem cells [Citation134].

Figure 2. The expression of HULC is increased in hepatocellular carcinoma. This lncRNA inhibits METTL3 binding with pri-MIR15A and decreases methylation of pri-MIR15A. Besides, HULC precludes binding of DGCR8 and DROSHA with this pri-miRNA, leading to a significant reduction in the levels of mature MIR15A. Downregulation of this miRNA results in the upregulation of SQSTM1, which contributes to the formation of autophagosome, suppression of PTEN, and induction of cancer [Citation40]. On the other hand, HULC enhances the binding of METTL3 with pri-MIR675 and increases MIR675 levels. This miRNA binds with 3ʹ UTR of HDAC5 mRNA and decreases its expression. Therefore, SIRT1 levels and the formation of autophagosomes are enhanced. This increases CCND1 synthesis and promotes the proliferation of cancer stem cells [Citation134].

lncRNAs and autophagy in nonmalignant conditions

HOTAIR participates in the pathogenesis of intervertebral disc degeneration through modulation of the AMPK-MTOR-ULK1 pathway and enhancement of autophagy, apoptosis, and senescence in the nucleus pulposus cells [Citation41]. In cerebral ischemic stroke, MALAT1 acts as a molecular sponge for MIR26B and MIR200C-3p to upregulate ULK2 and SIRT1, respectively. Both interactions lead to the enhancement of autophagy and the protection of brain microvascular endothelial cells against oxygen-glucose deprivation [Citation42,Citation43]. NEAT1 has a role in the pathogenesis of diverse disorders, including congenital heart disease and Parkinson disease, through enhancement of autophagy via different pathways [Citation44,Citation45]. A number of lncRNAs such as SPAG5-AS1, Gm5524, Gm15645, and SOX2-OT are involved in the regulation of autophagy in the context of diabetic nephropathy [Citation46–48]. Being upregulated in pre-eclampsia, the lncRNA H19 decreases cell viability but enhances invasion and autophagy in trophoblast cells possibly through induction of the PI3K-AKT-MTOR signaling [Citation49].

shows the list and function of autophagy-related lncRNAs.

Table 3. List of autophagy-associated lncRNAs

Vault RNAs (vtRNA) as a group of small ncRNAs being produced by RNA polymerase III can bind with the autophagy receptor SQSTM1 to suppress SQSTM1-dependent autophagy. Mechanistically, vtRNAs binding with SQSTM1 interferes with the oligomerization of SQSTM1 [Citation50]. Notably, the mechanism by which ncRNA may directly regulate protein function in the context of autophagy is implicated in cellular viability [Citation50,Citation51].

Expression levels of autophagy-related lncRNAs can predict the prognosis of patients with diverse cancer types. Most studies in this regard have been performed in patients with hepatocellular carcinoma. HNF1A-AS1, HOTAIR, HAGLROS, SNHG11, and LNCRNA-ATB are among lncRNAs whose upregulation confer unfavorable outcome in this kind of cancer [Citation35,Citation52–55]. summarizes the results of studies that assessed the association between expression levels of autophagy-related lncRNAs and patients’ prognosis. Moreover, few studies have appraised the diagnostic role of these lncRNAs in cancer patients. These studies are also summarized in .

Table 4. Prognostic/diagnostic value of autophagy-related lncRNAs in patients with cancers

Discussion

As a conserved process for the elimination of misfolded proteins and damaged organelles, autophagy is involved in the pathogenesis of several disorders. Autophagy is regulated by both lncRNAs and miRNAs. LncRNAs mostly regulate autophagy through modulation of expression of ATG genes. Their function is exerted through their ceRNA role in which they alter the function of autophagy-related miRNAs [Citation56]. Notably, autophagy itself can regulate the expression of several lncRNAs. An example of this type of regulation is represented by the lncRNA PVT1. The expression of this upregulated lncRNA in diabetic patients is downregulated by autophagy suppression [Citation57]. Globally, the role of autophagy-associated ncRNAs has been mostly assessed in cancers. Autophagy-related ncRNAs have remarkable survival in patients with diverse types of cancers.

The role of miRNAs/lncRNAs in the regulation of autophagy is mostly appraised in the context of cancer. Autophagy is regarded as a “dual sword” in the pathogenesis of cancer. Mostly, it preserves the homeostasis of the cancer milieu by affording nutritional supplements in situations of hypoxia and nutrient shortage. Yet, in certain conditions, autophagy can repress carcinogenesis [Citation58]. This note should be considered in the appraisal of the role of autophagy-related ncRNAs in the carcinogenic process. Moreover, autophagy has a fundamental role in the pathogenesis of several age-related conditions such as intervertebral disc degeneration, ischemia-related disorders such as myocardial infarction and cerebral ischemia, and diabetic-related complications. Thus, miRNAs/lncRNAs that regulate this process are putative therapeutic targets for a wide range of disorders. It is worth mentioning that while autophagy has a protective role against cell injury in cerebral ischemic stroke, in many of the mentioned conditions, it aggravates the pathogenic situation. Therefore, the direction of effects of autophagy in human pathologies should be considered in the design of therapeutic strategies. Moreover, it is possible that autophagy-related lncRNAs/miRNAs modulate specific targets or pathways in each tissue. This is particularly important for miRNAs as they can have several targets with variable levels of complementarity.

In addition to the regulatory role of ncRNAs on autophagy, recent studies indicate that autophagy regulates ncRNA biology. For example, autophagy selectively targets key components of the miRNA machinery to regulate miRNAs stability and function [Citation59,Citation60]. DICER1 and the principal miRNA effector, AGO2, is degraded through the selective autophagy receptor CALCOCO2/NDP52 [Citation60]. Moreover, the autophagy machinery has been reported to regulate intracellular and extracellular transport of RNA-binding proteins and ncRNAs. For instance, the LC3-conjugation system regulates the packaging of RNA-binding proteins into extracellular vesicles [Citation61]. Furthermore, ATG5 has been demonstrated to diminish nuclear transport of MIR126-5p [Citation51]. Finally, the MTORC1 pathway and autophagy control the proper assembly of RNA-induced Silencing complexes (RISCs), therefore affecting miRNA-related functions [Citation62].

According to the complexity of the autophagy process and involvement of several ncRNAs in the regulation of this process, integrative system biology-based methods are the preferred strategies for assessment of expression profile and function of miRNAs and lncRNAs and identification of the functional networks in this process. Each module in this network can be applied as a therapeutic target for disorders that are associated with autophagy. It is worth mentioning that with the constant influx of novel researchers in this field, it is necessary to outline standards for this kind of research. Importantly, investigators should apply these guidelines to ensure appropriate study design [Citation63].

Finally, autophagy-associated lncRNAs and miRNAs can predict patients’ outcomes in diverse cancer types. However, the prognostic role of these transcripts has not been assessed in other pathologic conditions. Thus, future studies should focus on this field to unravel the diagnostic/prognostic role of miRNAs and lncRNAs in these conditions to design personalized approaches for these disorders.

Acknowledgments

This study was financially supported by Shahid Beheshti University of Medical Sciences.

Disclosure statement

The authors declare they have no conflict of interest.

References

  • Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221(1):3–12. PubMed PMID: 20225336. eng.
  • Nakatogawa H, Suzuki K, Kamada Y, et al. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol. 2009;10(7):458–467.
  • Saftig P, Beertsen W. Eskelinen E-L. LAMP-2: a control step for phagosome and autophagosome maturation. Autophagy. 2008;4(4):510–512.
  • Yao H, Han B, Zhang Y, Shen L, Huang R. Non-coding RNAs and autophagy. Autophagy: biology and diseases. 2019;199–220.
  • Zhang P, Wu W, Chen Q, et al. Non-coding RNAs and their integrated networks. J Integr Bioinform. 2019;16(3):20190027. PubMed PMID: 31301674. eng.
  • Johnsson P, Lipovich L, Grandér D, et al. Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta. 2014;1840(3):1063–1071. PubMed PMID: 24184936. Epub 10/27. eng.
  • Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458(7235):223–227.
  • Ponjavic J, Ponting CP, Lunter G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res. 2007;17(5):556–565.
  • Warnefors M, Liechti A, Halbert J, et al. Conserved microRNA editing in mammalian evolution, development and disease. Genome Biol. 2014;15(6):R83–R. PubMed PMID: 24964909. eng.
  • Dahariya S, Paddibhatla I, Kumar S, et al. Long non-coding RNA: classification, biogenesis and functions in blood cells. Mol Immunol. 2019 Aug;112:82–92. PubMed PMID: 31079005. Epub 2019/05/13. eng.
  • Bartel DP. Metazoan MicroRNAs. Cell. 2018 Mar 22;173(1):20–51. PubMed PMID: 29570994. Pubmed Central PMCID: PMC6091663. Epub 2018/03/24. eng.
  • Liu X, Zhong L, Li P, et al. microRNA‐100 enhances autophagy and suppresses migration and invasion of renal cell carcinoma cells via disruption of NOX4‐dependent mTOR pathway. Clin Transl Sci. 2020. In press.
  • Wei L, Chen Z, Cheng N, et al. MicroRNA-126 inhibit viability of colorectal cancer cell by repressing mTOR induced apoptosis and autophagy. Oncol Targets Ther. PubMed PMID: 32273718. Pubmed Central PMCID: PMC7102882 2020;13: 2459–2468.
  • Fu X-T, Shi Y-H, Zhou J, et al. MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma. Cancer Lett. 2018;412:108–117.
  • Chen W, Li Z, Liu H, et al., MicroRNA-30a targets BECLIN-1 to inactivate autophagy and sensitizes gastrointestinal stromal tumor cells to imatinib., Cell Death Dis, 2020 Mar 23 11:3 198 PubMed PMID: 32251287. Pubmed Central PMCID: PMC7090062.
  • Shi Y, Yang Z, Zhang T, et al. SIRT1-targeted miR-543 autophagy inhibition and epithelial-mesenchymal transition promotion in Helicobacter pylori CagA-associated gastric cancer. Cell Death Dis. 2019 Aug 19;10(9):625. PubMed PMID: 31423013. Pubmed Central PMCID: PMC6698481.
  • Qi J, Luo X, Ma Z, et al. Downregulation of miR-26b-5p, miR-204-5p, and miR-497-3p expression facilitates exercise-induced physiological cardiac hypertrophy by augmenting autophagy in rats. Front Genet. 2020;11(78). PubMed PMID: 32140172. Pubmed Central PMCID: PMC7042403.
  • Wang Y, Sun H, Song J, et al. MiR-139-5p protect against myocardial ischemia and reperfusion (I/R) injury by targeting autophagy-related 4D and inhibiting AMPK/mTOR/ULK1 pathway. Int J Clin Exp Pathol. 2017;10(9): 10140–10151. PubMed PMID: 31966906. Pubmed Central PMCID: PMC6965934.
  • Zhao P, Zhang BL, Liu K, et al. Overexpression of miR-638 attenuated the effects of hypoxia/reoxygenation treatment on cell viability, cell apoptosis and autophagy by targeting ATG5 in the human cardiomyocytes. Eur Rev Med Pharmacol Sci. 22(23) PubMed PMID: 30556888.:8462–8471. 2018 Dec;.
  • Zhang C, Liang R, Gan X, et al. MicroRNA-384-5p/Beclin-1 as potential indicators for epigallocatechin gallate against Cardiomyocytes Ischemia reperfusion injury by inhibiting autophagy via PI3K/Akt pathway. Drug Des Devel Ther. 2019;13:3607–3623. [ PubMed PMID: 31802847. Pubmed Central PMCID: PMC6802542].
  • Xu Y, Xu Y, Wang S. Effect of exosome-carried miR-30a on myocardial apoptosis in myocardial ischemia-reperfusion injury rats through regulating autophagy. Eur Rev Med Pharmacol Sci. 2019;23(16):7066–7072.
  • Zhang L, Cheng R, Huang Y. MiR-30a inhibits BECN1-mediated autophagy in diabetic cataract. Oncotarget. 2017 Sep 29;8(44):77360–77368. PubMed PMID: 29100392. Pubmed Central PMCID: PMC5652784.
  • Zhou DM, Sun LL, Zhu J, et al. MiR-9 promotes angiogenesis of endothelial progenitor cell to facilitate thrombi recanalization via targeting TRPM7 through PI3K/Akt/autophagy pathway. J Cell Mol Med. 24(8) PubMed PMID: 32147957. Pubmed Central PMCID: PMC7176881.:4624–4632. 2020 Apr;.
  • Cai C, Min S, Yan B, et al. MiR-27a promotes the autophagy and apoptosis of IL-1beta treated-articular chondrocytes in osteoarthritis through PI3K/AKT/mTOR signaling. Aging (Albany NY). 2019 Aug 27;11(16):6371–6384. PubMed PMID: 31460867. Pubmed Central PMCID: PMC6738432.
  • Lian WS, Ko JY, Wu RW, et al. MicroRNA-128a represses chondrocyte autophagy and exacerbates knee osteoarthritis by disrupting Atg12. Cell Death Dis. 2018 Sep 11;9(9):919. PubMed PMID: 30206206. Pubmed Central PMCID: PMC6134128.
  • Sun W, Li Y, Wei S. miR-4262 regulates chondrocyte viability, apoptosis, autophagy by targeting SIRT1 and activating PI3K/AKT/mTOR signaling pathway in rats with osteoarthritis. Exp Ther Med. 15(1) PubMed PMID: 29434702. Pubmed Central PMCID: PMC5772979:1119–1128. 2018 Jan;.
  • Li H, Li Z, Pi Y, et al. MicroRNA-375 exacerbates knee osteoarthritis through repressing chondrocyte autophagy by targeting ATG2B. Aging (Albany NY). 12(8). PubMed PMID: 32335541. 7248–7261. 2020 Apr 26.
  • Brest P, Lapaquette P, Souidi M, et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn’s disease. Nature Genet. 2011;43(3):242–245.
  • Li M, Zhang S, Qiu Y, et al. Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3. Cell Death Dis. 2017 Mar 23;8(3):e2699. PubMed PMID: 28333149. Pubmed Central PMCID: PMC5386569. Epub 2017/03/24. eng.
  • Fang K, Sideri A, Law IKM, et al. 196 identification of a novel Substance P (SP)-Neurokinin-1 Receptor (NK-1R) microRNA-221 inflammatory network in human colonic epithelial cells. Gastroenterology. 2014;146(5):S–51.
  • Liao D, Li T, Ye C, et al. miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells. Exp Ther Med. 2018 Feb;;15(2):1712–1717. PubMed PMID: 29434757. Pubmed Central PMCID: PMC5774445.
  • Huang KT, Kuo IY, Tsai MC, et al. Factor VII-INDUCED microRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma. Mol Ther Nucleic Acids. 2017 Dec 15 PubMed PMID: 29246306. Pubmed Central PMCID: PMC5675721.;9:274–283.
  • Moharamoghli M, Hassan-Zadeh V, Dolatshahi E, et al. The expression of GAS5, THRIL, and RMRP lncRNAs is increased in T cells of patients with rheumatoid arthritis. Clin Rheumatol. 2019;38(11):3073–3080.
  • Sun AG, Meng FG, Wang MG. CISD2 promotes the proliferation of glioma cells via suppressing beclin1mediated autophagy and is targeted by microRNA449a. Mol Med Rep. 2017 Dec;16(6):7939–7948. PubMed PMID: 28983596. Pubmed Central PMCID: PMC5779876.
  • Yang L, Zhang X, Li H, et al. The long noncoding RNA HOTAIR activates autophagy by upregulating ATG3 and ATG7 in hepatocellular carcinoma. Mol Biosyst. 2016;12(8):2605–2612.
  • Fu Z, Luo W, Wang J, et al. Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma. Biochem Biophys Res Commun. 492(3). PubMed PMID: 28834690. 480–486. 2017 Oct 21.
  • Ma R, Zhang B, Zhang Z, et al. MALAT1 knockdown inhibits cell migration and invasion by suppressing autophagy through miR-384/GOLM1 axis in glioma. Eur Rev Med Pharmacol Sci. 2020;24(5):2601–2615.
  • Liu F, Ai FY, Zhang DC, et al. LncRNA NEAT1 knockdown attenuates autophagy to elevate 5‐FU sensitivity in colorectal cancer via targeting miR‐34a. Cancer Med. 2020;9(3):1079–1091.
  • Xin L, Zhou Q, Yuan Y-W, et al. METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy. J Cancer Res Clin Oncol. 2019;145(10):2507–2517.
  • Xin X, Wu M, Meng Q, et al. Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a. Mol Cancer. 2018;17(1):94.
  • Sheng H, Guo Y, Cao D, et al. MiR-429-5p attenuates the migration and invasion of malignant melanoma by targeting LIMK1. Eur Rev Med Pharmacol Sci. 2020;24(5):2625–2631.
  • Wang S, Han X, Mao Z, et al. MALAT1 lncRNA induces autophagy and protects brain microvascular endothelial cells against oxygen–glucose deprivation by binding to miR-200c-3p and upregulating SIRT1 expression. Neuroscience. 2019;397:116–126.
  • Li Z, Li J, Tang N. Long noncoding RNA Malat1 is a potent autophagy inducer protecting brain microvascular endothelial cells against oxygen-glucose deprivation/reoxygenation-induced injury by sponging miR-26b and upregulating ULK2 expression. Neuroscience. 2017;354:1–10.
  • Lv Y, Liu Z, Huang J, et al. LncRNA nuclear-enriched abundant transcript 1 regulates hypoxia-evoked apoptosis and autophagy via mediation of microRNA-181b. Mol Cell Biochem. 2020;464(1):193–203.
  • Yan W, Chen Z-Y, Chen J-Q, et al. LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson’s disease through stabilizing PINK1 protein. Biochem Biophys Res Commun. 2018;496(4):1019–1024.
  • Nabipoorashrafi SA, Shomali N, Sadat‐Hatamnezhad L, et al. miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro. IUBMB Life. 2020;72(9):2034–2044.
  • Feng Y, Chen S, Xu J, et al. Dysregulation of lncRNAs GM5524 and GM15645 involved in high‑glucose‑induced podocyte apoptosis and autophagy in diabetic nephropathy. Mol Med Rep. 2018;18(4):3657–3664.
  • Zhang Y, Chang B, Zhang J, et al. LncRNA SOX2OT alleviates the high glucose-induced podocytes injury through autophagy induction by the miR-9/SIRT1 axis. Exp Mol Pathol. 2019;110:104283.
  • Xu J, Xia Y, Zhang H, et al. Overexpression of long non-coding RNA H19 promotes invasion and autophagy via the PI3K/AKT/mTOR pathways in trophoblast cells. Biomed Pharmacother. 2018;101:691–697.
  • Horos R, Büscher M, Kleinendorst R, et al. The small Non-coding vault RNA1-1 acts as a riboregulator of autophagy. Cell. 2019 Feb 21;176(5):1054–67e12. PubMed PMID: 30773316. Epub 2019/02/19. eng.
  • Santovito D, Egea V, Bidzhekov K, et al. Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis. Sci Transl Med. 2020 Jun 3;12(546):eaaz2294. PubMed PMID: 32493793. Epub 2020/06/05. eng.
  • Xu F, Hong F, Li Y, et al. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cells apoptosis by reducing HIF-1α/mTOR mediated autophagy. 2020.
  • Huang W, Huang F, Lei Z, et al. LncRNA SNHG11 promotes proliferation, migration, apoptosis, and autophagy by regulating hsa-miR-184/AGO2 in HCC. OncoTargets Therapy. 2020;13:413.
  • Wei H, Hu J, Pu J, et al. Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells. Int Immunopharmacol. 2019;73:72–80.
  • Wang C-Z, Yan G-X, Dong D-S, et al. LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma. World J Gastroenterol. 2019;25(35):5310.
  • Yang L, Wang H, Shen Q, et al. Long non-coding RNAs involved in autophagy regulation. Cell Death Dis. 2017;8(10):e3073–e.
  • Li Z, Hao S, Yin H, et al. Autophagy ameliorates cognitive impairment through activation of PVT1 and apoptosis in diabetes mice. Behav Brain Res. 2016;305:265–277.
  • Islam Khan MZ, Tam SY, Law HKW. Autophagy-modulating long non-coding RNAs (LncRNAs) and their molecular events in cancer. Front Genet. 2019;9:750. [ PubMed PMID: 30693021. eng.].
  • Liao CC, Ho MY, Liang SM, et al. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P. Autophagy. 2018;14(12):2065–2082. PubMed PMID: 30081720. Pubmed Central PMCID: PMC6984764. Epub 2018/08/08. eng.
  • Gibbings D, Mostowy S, Jay F, et al. Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol. 14(12) PubMed PMID: 23143396. Pubmed Central PMCID: PMC3771578. Epub 2012/11/13. eng.:1314–1321. 2012 Dec;.
  • Leidal AM, Huang HH, Marsh T, et al. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat Cell Biol. 2020 Feb;;22(2):187–199. PubMed PMID: 31932738. Pubmed Central PMCID: PMC7007875. Epub 2020/01/15. eng.
  • La Rocca G, Olejniczak SH, González AJ, et al. In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA. Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):767–772. PubMed PMID: 25568082. Pubmed Central PMCID: PMC4311832. Epub 2015/01/09. eng.
  • Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222. PubMed PMID: 26799652. Pubmed Central PMCID: PMC4835977. Epub 2016/01/23. eng.
  • Liu X, Zhong L, Li P, et al. microRNA-100 enhances autophagy and suppresses migration and invasion of renal cell carcinoma cells via disruption of NOX4-dependent mTOR pathway. Clin Transl Sci. 2020 May 1. PubMed PMID: 32356935. In press.
  • Huang W, Zeng C, Hu S, et al. ATG3, a Target of miR-431-5p, promotes proliferation and invasion of colon cancer via promoting autophagy. Cancer Manag Res. PubMed PMID: 31849517. Pubmed Central PMCID: PMC6911302. 2019;11(102):75–85.
  • Qian LB, Jiang SZ, Tang XQ, et al. Exacerbation of diabetic cardiac hypertrophy in OVE26 mice by angiotensin II is associated with JNK/c-Jun/miR-221-mediated autophagy inhibition. Oncotarget. 2017 Dec 5;8(63):106661–106671. PubMed PMID: 29290979. Pubmed Central PMCID: PMC5739764.
  • Yang Y, Sun Y, Wang H, et al. MicroRNA-221 induces autophagy through suppressing HDAC6 expression and promoting apoptosis in pancreatic cancer. Oncol Lett. 2018 Dec;16(6):7295–7301. PubMed PMID: 30546469. Pubmed Central PMCID: PMC6256293.
  • Liao W, Zhang Y. MicroRNA-381 facilitates autophagy and apoptosis in prostate cancer cells via inhibiting the RELN-mediated PI3K/AKT/mTOR signaling pathway. Life Sci PubMed PMID: 32304760. 2020;254:117672. Apr15.
  • Ling Z, Liu D, Zhang G, et al. miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer. Oncol Rep. 38(3). PubMed PMID: 29094170. 1621–1628. 2017 Sep;.
  • Zhang YJ, Pan Q, Yu Y, et al. microRNA-519d induces autophagy and apoptosis of human hepatocellular carcinoma cells through activation of the AMPK signaling pathway via Rab10. Cancer Manag Res. 2020;12:2589–2602. [ PubMed PMID: 32346312. Pubmed Central PMCID: PMC7167370].
  • Cui X, Wang X, Zhou X, et al. miR-106a regulates cell proliferation and autophagy by targeting LKB1 in HPV-16-associated cervical cancer. Mol Cancer Res. 2020 Apr 28;18(8):1129–1141. PubMed PMID: 32345599.
  • Zhou Q, Dong J, Luo R, et al. MicroRNA-20a regulates cell proliferation, apoptosis and autophagy by targeting thrombospondin 2 in cervical cancer. Eur J Pharmacol. 5(844) PubMed PMID: 30513279.:102–109. 2019 Feb.
  • He W, Cheng Y. Inhibition of miR-20 promotes proliferation and autophagy in articular chondrocytes by PI3K/AKT/mTOR signaling pathway. Biomed Pharmacother. 2018 Jan;97:607–615. PubMed PMID: 29101804.
  • Yang Y, Luo H, Liu S, et al. Platelet microparticles-containing miR-4306 inhibits human monocyte-derived macrophages migration through VEGFA/ERK1/2/NF-κB signaling pathways. Ann Clin Exp Hypertens. 2019;41(5):481–491.
  • Gan X, Zhu H, Jiang X, et al. CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a. Mol Cancer. 2020 Feb 28;19(1):45. PubMed PMID: 32111227. Pubmed Central PMCID: PMC7047414.
  • Ba RQ, Liu J, Fan XJ, et al. Effects of miR-199a on autophagy by targeting glycogen synthase kinase 3beta to activate PTEN/AKT/mTOR signaling in an MPP(+) in vitro model of Parkinson’s disease. Neurol Res. 42(4). PubMed PMID: 32151238. 308–318. 2020 Apr;.
  • Li JP, Zhang HM, Liu MJ, et al. miR-133a-3p/FOXP3 axis regulates cell proliferation and autophagy in gastric cancer. J Cell Biochem. 121(5–6). PubMed PMID: 31904151. 3392–3405. 2020 Jun;.
  • Zhang HM, Li H, Wang GX, et al. MKL1/miR-5100/CAAP1 loop regulates autophagy and apoptosis in gastric cancer cells. Neoplasia. 2020 May;22(5):220–230. PubMed PMID: 32315812. Pubmed Central PMCID: PMC7167518.
  • Guo W, Chen Z, Chen Z, et al. Promotion of cell proliferation through inhibition of cell autophagy signalling pathway by Rab3IP is restrained by MicroRNA-532-3p in Gastric cancer. J Cancer. 2018;9(23):4363–4373. PubMed PMID: 30519341. Pubmed Central PMCID: PMC6277663.
  • Yuan KT, Li BX, Yuan YJ, et al. Deregulation of MicroRNA-375 inhibits proliferation and migration in gastric cancer in association with autophagy-mediated AKT/mTOR signaling pathways. Technol Cancer Res Treat. 2018 Jan 1 1533033818806499. PubMed PMID: 30355273. Pubmed Central PMCID: PMC6202745;17:153303381880649.
  • Yuan Y, Zhang Y, Han L, et al. miR-183 inhibits autophagy and apoptosis in gastric cancer cells by targeting ultraviolet radiation resistance-associated gene. Int J Mol Med. 42(6) PubMed PMID: 30221685.:3562–3570. 2018 Dec.
  • Ma L, Wang Z, Xie M, et al. Silencing of circRACGAP1 sensitizes gastric cancer cells to apatinib via modulating autophagy by targeting miR-3657 and ATG7. Cell Death Dis. 2020 Mar 5;11(3):169. PubMed PMID: 32139670. Pubmed Central PMCID: PMC7058073.
  • Wang H, Zhang Y, Wu Q, et al. miR-16 mimics inhibit TGF-beta1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells. Oncol Rep. 39(1) PubMed PMID: 29138833.:247–254. 2018 Jan.
  • Li S, Zeng X, Ma R, et al. MicroRNA-21 promotes the proliferation, migration and invasion of non-small cell lung cancer A549 cells by regulating autophagy activity via AMPK/ULK1 signaling pathway. Exp Ther Med. 2018 Sep; 16;2038(3):45. PubMed PMID: 30186437. Pubmed Central PMCID: PMC6122184.
  • He Y, Liu H, Jiang L, et al. miR-26 induces apoptosis and inhibits autophagy in non-small cell lung cancer cells by suppressing TGF-beta1-JNK signaling pathway. Front Pharmacol. 2018;9:1509. PubMed PMID: 30687089. Pubmed Central PMCID: PMC6333751.
  • Yu Y, Xiang N, Lin M, et al. miR- 26a sensitizes melanoma cells to dabrafenib via targeting HMGB1-dependent autophagy pathways. Drug Des Devel Ther. PubMed PMID: 31754297. Pubmed Central PMCID: PMC6825511 2019;13: 3717–3726.
  • Meng C, Liu Y, Shen Y, et al. MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation. Oncol Lett. 2018 Feb;;15(2):1435–1440. PubMed PMID: 29399189. Pubmed Central PMCID: PMC5774516.
  • Ju S, Liang Z, Li C, et al. The effect and mechanism of miR-210 in down-regulating the autophagy of lung cancer cells. Pathol Res Pract. 215(3). PubMed PMID: 30573163. 453–458. 2019 Mar;.
  • Ye C, Qi W, Dai S, et al. microRNA-223 promotes autophagy to aggravate lung ischemia-reperfusion injury by inhibiting the expression of transcription factor HIF2alpha. Am J Physiol Lung Cell Mol Physiol. 2020 Apr 8;319(1):L1–L10. PubMed PMID: 32267722.
  • Xu T, Yan W, Wu Q, et al. MiR-326 inhibits inflammation and promotes autophagy in silica-induced pulmonary fibrosis through targeting TNFSF14 and PTBP1. Chem Res Toxicol. 32(11). PubMed PMID: 31642316. 2192–2203. 2019 Nov 18.
  • Lou L, Tian M, Chang J, et al., MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7. Biomed Pharmacother, 2020 Feb 122:109692 PubMed PMID: 31918268 .
  • Yang ZY, Wang Y, Liu Q, et al. microRNA cluster MC-let-7a-1~let-7d promotes autophagy and apoptosis of glioma cells by down-regulating STAT3. CNS Neurosci Ther. 2020 Mar;26(3):319–331. PubMed PMID: 31868319. Pubmed Central PMCID: PMC7052808.
  • Zhang N, Qiu L, Li T, et al. MiR-449a attenuates autophagy of T-cell lymphoma cells by downregulating ATG4B expression. BMB Rep. 2020 Mar 16;53(5):254–259. PubMed PMID: 32172731.
  • Wu K, Huang J, Xu T, et al. MicroRNA-181b blocks gensenoside Rg3-mediated tumor suppression of gallbladder carcinoma by promoting autophagy flux via CREBRF/CREB3 pathway. Am J Transl Res. 2019;11(9):5776–5787. PubMed PMID: 31632547. Pubmed Central PMCID: PMC6789245.
  • Xiao Y, Diao Q, Liang Y, et al. 2415p promotes malignant melanoma cell autophagy and apoptosis via regulating ubiquitin D. Mol Med Rep. 16(6) PubMed PMID: 28983594.:8448–8454. 2017 Dec;.
  • Tong X, Wang X, Wang C, et al. Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3. BrJ Biomed Sci. 75(1) PubMed PMID: 28929922.:7–12. 2018 Jan;.
  • Pang F, Liu C, Cui Y, et al. miR-17-5p promotes proliferation and migration of CAL-27 human tongue squamous cell carcinoma cells involved in autophagy inhibition under hypoxia. Int J Clin Exp Pathol. 2019;12(6):2084–2091. PubMed PMID: 31934030. Pubmed Central PMCID: PMC6949637.
  • Cheng Y, Li Z, Xie J, et al. MiRNA-224-5p inhibits autophagy in breast cancer cells via targeting Smad4. Biochemical and Biophysical Research Communications. 506(4). PubMed PMID: 30389135. 793–798. 2018 Dec 2;.
  • Ai H, Zhou W, Wang Z, et al. microRNAs-107 inhibited autophagy, proliferation, and migration of breast cancer cells by targeting HMGB1. J Cell Biochem. 2018 Dec 2 PubMed PMID: 30506984. doi: https://doi.org/10.1002/jcb.28157
  • Qi H, Ren J, Ba L, et al. MSTN attenuates cardiac hypertrophy through inhibition of excessive cardiac autophagy by blocking AMPK/mTOR and miR-128/PPARgamma/NF-kappaB. Mol Ther Nucleic Acids. 2020 Mar 6 PubMed PMID: 31923740. Pubmed Central PMCID: PMC6951838;19:507–522.
  • Zhou S, Lei D, Bu F, et al. MicroRNA-29b-3p targets sparc gene to protect cardiocytes against autophagy and apoptosis in hypoxic-induced H9c2 cells. J Cardiovasc Transl Res. 12(4) PubMed PMID: 30560317.:358–365. 2019 Aug;.
  • Zhou F, Li Y, Huang Y, et al. Upregulation of CASP9 through NF-κB and its target MiR-1276 Contributed to TNFα-promoted apoptosis of cancer cells induced by doxorubicin. Int J Mol Sci. 2020;21(7):2290.
  • Hu S, Cao S, Tong Z, et al. FGF21 protects myocardial ischemia-reperfusion injury through reduction of miR-145-mediated autophagy. Am J Transl Res. 2018;10(11): 3677–3688. PubMed PMID: 30662618. Pubmed Central PMCID: PMC6291727.
  • Wu G, Yu W, Zhang M, et al. MicroRNA-145-3p suppresses proliferation and promotes apotosis and autophagy of osteosarcoma cell by targeting HDAC4. Artif Cells Nanomed Biotechnol. 2018;46(sup2):579–586. PubMed PMID: 29893594.
  • Zhou Z, Hu B, Lyu Q, et al. miR-384-5p promotes spinal cord injury recovery in rats through suppressing of autophagy and endoplasmic reticulum stress. Neurosci Lett. 14(727) PubMed PMID: 32243909.:134937. 2020 May.
  • Li X, Lou X, Xu S, et al. Knockdown of miR-372 inhibits nerve cell apoptosis induced by spinal cord Ischemia/Reperfusion injury via enhancing autophagy by up-regulating Beclin-1. J Mol Neurosci. 66(3) PubMed PMID: 30298297.:437–444. 2018 Nov;.
  • Chen J, Sun Q, Liu GZ, et al. Effect of miR-202-5p-mediated ATG7 on autophagy and apoptosis of degenerative nucleus pulposus cells. Eur Rev Med Pharmacol Sci. 24(2). PubMed PMID: 32016953. 517–525. 2020 Jan;.
  • Li W, Yang Y, Ba Z, et al. MicroRNA-93 regulates hypoxia-induced autophagy by targeting ULK1. Oxid Med Cell Longev. 2017;2709053. PubMed PMID: 29109831. Pubmed Central PMCID: PMC5646326.
  • Yang S, Abdulla R, Lu C, et al. Inhibition of microRNA-376b protects against renal interstitial fibrosis via inducing macrophage autophagy by upregulating atg5 in mice with Chronic Kidney disease. Kidney Blood Press Res. 2018;43(6):1749–1764. PubMed PMID: 30472709.
  • Li XY, Wang SS, Han Z, et al. Triptolide restores autophagy to alleviate diabetic renal fibrosis through the miR-141-3p/PTEN/Akt/mTOR pathway. Mol Ther Nucleic Acids. 2017 Dec 15 PubMed PMID: 29246323. Pubmed Central PMCID: PMC5602517;9:48–56.
  • Ye Z, Li ZH, He SZ. miRNA-1273g-3p involvement in development of diabetic retinopathy by modulating the autophagy-lysosome pathway. Med Sci Monit. 2017 Dec 3 PubMed PMID: 29197896. Pubmed Central PMCID: PMC5724349;23: 5744–5751.
  • Liu G, Kang X, Guo P, et al. miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1. Ren Fail. 42(1). PubMed PMID: 32340512. 333–342. 2020 Nov;.
  • Qiu S, Liu B, Mo Y, et al. MicroRNA-153-3p increases autophagy in sevoflurane-preconditioned mice to protect against ischaemic/reperfusion injury after knee arthroplasty. J Cell Mol Med. 24(9). PubMed PMID: 32239627. 5330–5340. 2020 May;.
  • Li YL, Tang JM, Chen XY, et al. MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy. Hum Cell. 2020 Apr 27;33(3):610–618. PubMed PMID: 32342278.
  • Wang N, Yang L, Zhang H, et al. MicroRNA-9a-5p alleviates ischemia injury after focal cerebral ischemia of the rat by targeting ATG5-mediated autophagy. Cell Physiol Biochem. 2018;45(1):78–87. PubMed PMID: 29316542.
  • Li W, Ren Y, Meng T, et al. miR-129-5p attenuates hypoxia-induced apoptosis in rat H9c2 cardiomyocytes by activating autophagy. J Gene Med. 2020 Apr 16;22(8):e3200 . PubMed PMID: 32298509.
  • Zhang H, Zhang X, Zhang J. MiR-129-5p inhibits autophagy and apoptosis of H9c2 cells induced by hydrogen peroxide via the PI3K/AKT/mTOR signaling pathway by targeting ATG14. Biochem Biophys Res Commun. 506(1) PubMed PMID: 30348524.:272–277. 2018 Nov 17.
  • Song H, Liu J, Wu X, et al. LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p. Aging (Albany NY). 2019 Nov 13;11(21):9794–9810. PubMed PMID: 31724536. Pubmed Central PMCID: PMC6874432.
  • Tao Z, Feng C, Mao C, et al. MiR-4465 directly targets PTEN to inhibit AKT/mTOR pathway-mediated autophagy. Cell Stress Chaperones. 2019 Jan;;24(1):105–113. PubMed PMID: 30421325. Pubmed Central PMCID: PMC6363616.
  • Sul OJ, Sung YB, Rajasekaran M et al. MicroRNA-155 induces autophagy in osteoclasts by targeting transforming growth factor beta-activated kinase 1-binding protein 2 upon lipopolysaccharide stimulation Bone 2018Nov 116 279–289 PubMed PMID: 30144578
  • Yin S, Yang S, Pan X, et al. MicroRNA155 promotes oxLDLinduced autophagy in human umbilical vein endothelial cells by targeting the PI3K/Akt/mTOR pathway. Mol Med Rep. 18(3). PubMed PMID: 30015881. Pubmed Central PMCID: PMC6102700. 2798–2806. 2018 Sep;.
  • Li Y, Jiang J, Liu W, et al. microRNA-378 promotes autophagy and inhibits apoptosis in skeletal muscle. Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10849–E58. PubMed PMID: 30373812. Pubmed Central PMCID: PMC6243236.
  • Dong S, Xiao Y, Ma X, et al. miR-193b increases the chemosensitivity of osteosarcoma cells by promoting FEN1-mediated autophagy. Onco Targets Ther. PubMed PMID: 31819503. Pubmed Central PMCID: PMC6878930 2019;12: 10089–10098.
  • Cai L, Liu X, Guo Q, et al. MiR-15a attenuates peripheral nerve injury-induced neuropathic pain by targeting AKT3 to regulate autophagy. Genes Genomics. 42(1) PubMed PMID: 31736006.:77–85. 2020 Jan;.
  • Yu Q, Zhao B, He Q, et al. microRNA-206 is required for osteoarthritis development through its effect on apoptosis and autophagy of articular chondrocytes via modulating the phosphoinositide 3-kinase/protein kinase B-mTOR pathway by targeting insulin-like growth factor-1. J Cell Biochem. 120(4) PubMed PMID: 30335903.:5287–5303. 2019 Apr;.
  • Yang F, Huang R, Ma H, et al. miRNA-411 regulates chondrocyte autophagy in osteoarthritis by targeting hypoxia-inducible factor 1 alpha (HIF-1alpha). Med Sci Monit. 2020 Feb 19 PubMed PMID: 32072994. Pubmed Central PMCID: PMC7043337;26: e921155.
  • Mi H, Wang X, Wang F, et al. miR-381 induces sensitivity of breast cancer cells to doxorubicin by inactivation of MAPK signaling via FYN. Eur J Pharmacol. 2018;839:66–75.
  • Liang Y, Chen X, Liang Z. MicroRNA-320 regulates autophagy in retinoblastoma by targeting hypoxia inducible factor-1alpha. Exp Ther Med. 14(3) PubMed PMID: 28962169. Pubmed Central PMCID: PMC5609094.:2367–2372. 2017 Sep;.
  • Ganesan S, Palani HK, Lakshmanan V, et al. Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia. Cell Death Dis. 2019 Sep 30;10(10):736. PubMed PMID: 31570693. Pubmed Central PMCID: PMC6769009.
  • Luan B, Sun C. MiR-138-5p affects insulin resistance to regulate type 2 diabetes progression through inducing autophagy in HepG2 cells by regulating SIRT1. Nutr Res. 2018 Nov;59:90–98. PubMed PMID: 30442237.
  • Sabater-Arcis M, Bargiela A, Furling D, et al. miR-7 restores phenotypes in myotonic dystrophy muscle cells by repressing hyperactivated autophagy. Mol Ther Nucleic Acids. 2020 Mar 6 PubMed PMID: 31855836. Pubmed Central PMCID: PMC6926285.;19: 278–292.
  • Fu XT, Shi YH, Zhou J, et al. MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma. Cancer Lett. 1(412). PubMed PMID: 29061507. 108–117. 2018 Jan .
  • Liu Z, Wei X, Zhang A, et al. Long non-coding RNA HNF1A-AS1 functioned as an oncogene and autophagy promoter in hepatocellular carcinoma through sponging hsa-miR-30b-5p. Biochem Biophys Res Commun. 2016;473(4):1268–1275.
  • Wang C, Jiang X, Li X, et al. Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy. Stem Cell Res Ther. 2020;11(1):1–14.
  • Chen Z-H, Wang W-T, Huang W, et al. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway. Cell Death Differ. 2017;24(2):212–224.
  • Yang L, Peng X, Jin H, et al. Long non-coding RNA PVT1 promotes autophagy as ceRNA to target ATG3 by sponging microRNA-365 in hepatocellular carcinoma. Gene. 2019;697:94–102.
  • Huang F, Chen W, Peng J, et al. LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis. Mol Cancer. 2018;17(1):98.
  • Chen J-F, Wu P, Xia R, et al. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Mol Cancer. 2018;17(1):6.
  • Luo D, Li L, Huo H, et al. MicroRNA-29b sensitizes osteosarcoma cells to doxorubicin by targeting matrix metalloproteinase 9 (MMP-9) in osteosarcoma. Eur Rev Med Pharmacol Sci. 2019;23(4):1434–1442.
  • Fu Z, Luo W, Wang J, et al. Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma. Biochem Biophys Res Commun. 2017;492(3):480–486.
  • Gao D, Lv A, Li HP, et al. LncRNA MALAT‐1 elevates HMGB1 to promote autophagy resulting in inhibition of tumor cell apoptosis in multiple myeloma. J Cell Biochem. 2017;118(10):3341–3348.
  • Li L-J, Chai Y, Guo X-J, et al. The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma. Biomed Pharmacother. 2017;89:939–948.
  • Wu Q, Yi X. Down-regulation of long noncoding RNA MALAT1 protects hippocampal neurons against excessive autophagy and apoptosis via the PI3K/Akt signaling pathway in rats with epilepsy. J Mol Neurosci. 2018;65(2):234–245.
  • Shao G, Zhao Z, Zhao W, et al. Long non‑coding RNA MALAT1 activates autophagy and promotes cell proliferation by downregulating microRNA‑204 expression in gastric cancer. Oncol Lett. 2020;19(1):805–812.
  • Guo X, Wu X, Han Y, et al. MALAT1 protects cardiomyocytes from isoproterenol‐induced apoptosis through sponging miR‐558 to enhance ULK1‐mediated protective autophagy. J Cell Physiol. 2019;234(7):10842–10854.
  • Wang K, Yang C, Shi J, et al. Ox-LDL-induced lncRNA MALAT1 promotes autophagy in human umbilical vein endothelial cells by sponging miR-216a-5p and regulating Beclin-1 expression. Eur J Pharmacol. 2019;858:172338.
  • Zhu Y, Yang T, Duan J, et al. MALAT1/miR-15b-5p/MAPK1 mediates endothelial progenitor cells autophagy and affects coronary atherosclerotic heart disease via mTOR signaling pathway. Aging (Albany NY). 2019;11(4):1089.
  • Zheng S-Z, Sun P, Wang J-P, et al. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells. World J Gastroenterol. 2019;25(22):2752.
  • Liu H, Shi C, Deng Y. MALAT1 affects hypoxia-induced vascular endothelial cell injury and autophagy by regulating miR-19b-3p/HIF-1α axis. Mol Cell Biochem. 2020;474(1–2):1–10.
  • Huang J, Yang Y, Fang F, et al. MALAT1 modulates the autophagy of retinoblastoma cell through miR‐124‐mediated stx17 regulation. J Cell Biochem. 2018;119(5):3853–3863.
  • Yuan YL, Yu H, Mu S-M, et al. MiR-26a-5p inhibits cell proliferation and enhances doxorubicin sensitivity in HCC cells via targeting AURKA. Technol Cancer Res Treat. 2019;18:1533033819851833.
  • Song T-F, Huang L-W, Yuan Y, et al. LncRNA MALAT1 regulates smooth muscle cell phenotype switch via activation of autophagy. Oncotarget. 2018;9(4):4411.
  • Lang C, Xu M, Zhao Z, et al. MicroRNA96 expression induced by low‑dose cisplatin or doxorubicin regulates chemosensitivity, cell death and proliferation in gastric cancer SGC7901 cells by targeting FOXO1. Oncol Lett. 2018;16(3):4020–4026.
  • Xiu Y-L, Sun K-X, Chen X, et al. Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3. Oncotarget. 2017;8(19):31714.
  • Cao Y, Wen J, Li Y, et al. Uric acid and sphingomyelin enhance autophagy in iPS cell-originated cardiomyocytes through lncRNA MEG3/miR-7-5p/EGFR axis. Artif Cells Nanomed Biotechnol. 2019;47(1):3774–3785.
  • Li M, Cui J, Niu W, et al. Long non-coding PCED1B-AS1 regulates macrophage apoptosis and autophagy by sponging miR-155 in active tuberculosis. Biochem Biophys Res Commun. 2019;509(3):803–809.
  • Ke Z, Lu J, Zhu J, et al. Down-regulation of lincRNA-EPS regulates apoptosis and autophagy in BCG-infected RAW264. 7 macrophages via JNK/MAPK signaling pathway. Infection. Gene Evol. 2020;77:104077.
  • Zhou Z, Xu H, Liu B, et al. Suppression of lncRNA RMRP ameliorates oxygen-glucose deprivation/re-oxygenation-induced neural cells injury by inhibiting autophagy and PI3K/Akt/mTOR-mediated apoptosis. Biosci Rep. 2019;39:6.
  • Ren X, Wan C, Niu Y. Overexpression of lnc RNA TCTN 2 protects neurons from apoptosis by enhancing cell autophagy in spinal cord injury. FEBS Open Bio. 2019;9(7):1223–1231.
  • Qin Y, Sun W, Zhang H, et al. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer. Endocrine. 2018;59(3):555–564.
  • Su Y, Lu J, Chen X, et al. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway. J Cancer Res Clin Oncol. 2019;145(3):573–588.
  • Zhou M, Zou Y, Xue Y, et al. Long non-coding RNA H19 protects acute myocardial infarction through activating autophagy in mice. Eur Rev Med Pharmacol Sci. 2018;22(17):5647–5651.
  • Zhuo C, Jiang R, Lin X, et al. H19 inhibits autophagy by epigenetically silencing of DIRAS3 in diabetic cardiomyopathy. Oncotarget. 2017;8(1):1429.
  • Xiong H, Shen J, Chen Z, et al. H19/let‑7/Lin28 ceRNA network mediates autophagy inhibiting epithelial‑mesenchymal transition in breast cancer. Int J Oncol. 2020;56(3):794–806.
  • Feng Y, Xu W, Zhang W, et al. DCRF regulates cardiomyocyte autophagy by targeting miR-551b-5p in diabetic cardiomyopathy. Theranostics. 2019;9(15):4558.
  • Fan Y, Zhao X, Lu K, et al. LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson’s disease via ablating microRNA-125b-5p. Brain Res Bull. 2020;157:119–127.
  • Qian C, Ye Y, Mao H, et al. Downregulated lncRNA-SNHG1 enhances autophagy and prevents cell death through the miR-221/222/p27/mTOR pathway in Parkinson’s disease. Exp Cell Res. 2019;384(1):111614.
  • Zhu X, Yang G, Xu J, et al. Silencing of SNHG6 induced cell autophagy by targeting miR-26a-5p/ULK1 signaling pathway in human osteosarcoma. Cancer Cell Int. 2019;19(1):82.
  • Tian F, Wang J, Zhang Z, et al. SNHG7/miR-34a-5p/SYVN1 axis plays a vital role in proliferation, apoptosis and autophagy in osteoarthritis. Biol Res. 2020;53(1):1–11.
  • Yao X, Yao R, Huang F, et al. SNHG12 as a potent autophagy inducer exerts neuroprotective effects against cerebral ischemia/reperfusion injury. Biochem Biophys Res Commun. 2019;514(2):490–496.
  • Zeng C, Fan D, Xu Y, et al. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis. Biochem Pharmacol. 2020;174:113795.
  • Liu K, Hou Y, Liu Y, et al. SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. J Biomed Sci. 2017;24(1):46.
  • Wen Y, Gong X, Dong Y, et al. Long non coding RNA SNHG16 Facilitates proliferation, migration, invasion and autophagy of neuroblastoma cells via sponging miR-542-3p and upregulating ATG5 expression. OncoTargets Therapy. 2020;13:263.
  • Wang Z, LncRNA JJ. SLCO4A1-AS1 promotes colorectal cancer cell proliferation by enhancing autophagy via miR-508-3p/PARD3 axis. Aging (Albany NY). 2019;11(14):4876.
  • Zhang W, Yuan W, Song J, et al. LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer by inhibiting hypoxia-induced autophagy through inactivation of HIF-1α. Biochimie. 2018;144:21–27.
  • Liu L, Wang H-J, Meng T, et al. lncRNA GAS5 inhibits cell migration and invasion and promotes autophagy by targeting miR-222-3p via the GAS5/PTEN-signaling pathway in CRC. Mol Ther Nucl Acids. 2019;17:644–656.
  • Liang W, Fan T, Liu L, et al. Knockdown of growth-arrest specific transcript 5 restores oxidized low-density lipoprotein-induced impaired autophagy flux via upregulating miR-26a in human endothelial cells. Eur J Pharmacol. 2019;843:154–161.
  • Liu E, Sun X, Li J, et al. miR‑30a‑5p inhibits the proliferation, migration and invasion of melanoma cells by targeting SOX4. Mol Med Rep. 2018;18(2):2492–2498.
  • Gao M, Li C, Xu M, et al. LncRNA UCA1 attenuates autophagy-dependent cell death through blocking autophagic flux under arsenic stress. Toxicol Lett. 2018;284:195–204.
  • Su Y, Yao S, Zhao S, et al. CCAT1 functions as apoptosis inhibitor in podocytes via autophagy inhibition. J Cell Biochem. 2020;121(1):621–631.
  • Su Q, Liu Y, Lv X-W, et al. Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1-and Rac1-induced autophagy. J Mol Cell Cardiol. 2019;133:12–25.
  • Zhu Z, LncRNA ZC. AK139128 promotes cardiomyocyte autophagy and apoptosis in myocardial hypoxia-reoxygenation injury. Life Sci. 2019;116705. DOI:https://doi.org/10.1016/j.lfs.2019.116705
  • Yu S, Dong B, Fang Z, et al. Knockdown of lnc RNA AK 139328 alleviates myocardial ischaemia/reperfusion injury in diabetic mice via modulating miR‐204‐3p and inhibiting autophagy. J Cell Mol Med. 2018;22(10):4886–4898.
  • Huang Z, Ye B, Wang Z, et al. Inhibition of LncRNA-HRIM increases cell viability by regulating autophagy levels during hypoxia/reoxygenation in myocytes. Cell Physiol Biochem. 2018;46(4):1341–1351.
  • Wu D, Zhang J, Lu Y, et al. miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1. Cancer Gene Ther. 2019;26(3):74–82.
  • Yao L, Yang L, Song H, et al. Silencing of lncRNA XIST suppresses proliferation and autophagy and enhances vincristine sensitivity in retinoblastoma cells by sponging miR-204-5p. Eur Rev Med Pharmacol Sci. 2020;24(7):3526–3537.
  • Liang H, Su X, Wu Q, et al. LncRNA 2810403D21Rik/Mirf promotes ischemic myocardial injury by regulating autophagy through targeting Mir26a. Autophagy. 2019;16(6):1077–1091.
  • Chen J, Zhou C, Li J, et al. miR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3. Int J Mol Med. 2018;41(4):1855–1866.
  • Gu Z, Hou Z, Zheng L, et al. LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5. Biomed Pharmacother. 2018;104:110–118.
  • Pan Z, Wu C, Li Y, et al. LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p. Biomed Pharmacother. 2020;122:109707.
  • Wang Z, Wang J, Wang K, et al. FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer. Eur Rev Med Pharmacol Sci. 2020;24(5):2281–2293.
  • Yang C, Shen S, Zheng X, et al. Long non‐coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4. Faseb J. 2020;34(5):6055–6069.
  • Guo F-X, Wu Q, Li P, et al. The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling. Cell Death Differ. 2019;26(9):1670–1687.
  • Tu C, Chen W, Wang S, et al. MicroRNA‐383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2. J Cell Mol Med. 2019;23(11):7190–7199.
  • Xue K, Li J, Nan S, et al. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206. Life Sci. 2019;231:116459.
  • Mai C, Qiu L, Zeng Y, et al. LncRNA Lethe protects sepsis-induced brain injury via regulating autophagy of cortical neurons. Eur Rev Med Pharmacol Sci. 2019;23(11):4858–4864.
  • Yang Y, Li Y, Ding L, et al. Regulatory effect of lncRNA NKILA on autophagy induced by sepsis kidney injury. Eur Rev Med Pharmacol Sci. 2019;23(18):8011–8017.
  • Luan W, Zhou Z, Zhu Y, et al. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase. Biochem Biophys Res Commun. 2018;495(1):46–52.
  • Li P, He J, Yang Z, et al. ZNNT1 long noncoding RNA induces autophagy to inhibit tumorigenesis of uveal melanoma by regulating key autophagy gene expression. Autophagy. 2019;16(7):1186–1199.
  • Cai Q, Wang S, Jin L, et al. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. Mol Cancer. 2019;18(1):82.
  • Yang Y, Chen D, Liu H, et al. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma. Cell Death Dis. 2019;10(2):1–16.
  • Zhao Y, Zhang F, Pan Z, et al. NR_003923 promotes cell proliferation, migration, fibrosis, and autophagy via the miR-760/miR-215-3p/IL22RA1 axis in human Tenon’s capsule fibroblasts. Cell Death Dis. 2019;10(8):1–13.
  • Zhou W, Zhang S, Li J, et al. lncRNA TINCR participates in ALA‐PDT‐induced apoptosis and autophagy in cutaneous squamous cell carcinoma. J Cell Biochem. 2019;120(8):13893–13902.
  • Zhang X, Liu J, Gu Y, et al. Down‐regulation of lncRNA OGFRP1 induces autophagy and growth inhibition by AKT/mTOR signaling pathway in HCAECs. Cell Biol Int. 2019;43(2):158–166.
  • Li J, Zhai D, Huang Q, et al. DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways. Eur Rev Med Pharmacol Sci. 2019;23(14):6091–6104.
  • Zhao H, Wang X, Feng X, et al. Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma. J Neurooncol. 2018;140(2):281–288.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.